UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042977
Receipt number R000049067
Scientific Title Skin irritation patch test to evaluate skin safety of Cannabidiol (CBD) in healthy Female subjects
Date of disclosure of the study information 2021/02/15
Last modified on 2021/03/23 21:48:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Skin irritation patch test to evaluate skin safety of Cannabidiol (CBD) in healthy Female subjects

Acronym

Cannabidiol patch test

Scientific Title

Skin irritation patch test to evaluate skin safety of Cannabidiol (CBD) in healthy Female subjects

Scientific Title:Acronym

Cannabidiol patch test

Region

Japan


Condition

Condition

Health Female

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the skin safety of CBD with skin irritation patch test in healthy female subject.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Assessment of skin irritation based on the ICDRG (International Contact Dermatitis Research Group) Standards

Key secondary outcomes

Safety: Evaluated for all adverse events


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Diagnosis

Type of intervention

Food

Interventions/Control_1

CBD concentration 0%

Interventions/Control_2

CBD concentration 0.1%

Interventions/Control_3

CBD concentration 0.5%

Interventions/Control_4

CBD concentration 1.0%

Interventions/Control_5

CBD concentration 1.5%

Interventions/Control_6

unit only

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

55 years-old >=

Gender

Female

Key inclusion criteria

1) Female between the Age from 20<= <45 at the time of obtaining consent
2) Those who have the ability to consent, comply with matters to be complied with while participating in the examination, undergo the pre-examination stipulated in this test implementation plan, and can declare subjective symptoms, etc.
3) Those who do not have skin diseases such as dermatitis and eczema at the site where study drug will be administered
4) A person who has no history of rashes caused by bandages and contact dermatitis caused by metal, cosmetics, household products, etc.
5) Those who have a BMI (Body Mass Index) of 18.5 or more and 30.0 or less at the time of screening visit

Key exclusion criteria

) Those who have a history of evaluation of this test and considered to have an impact on safety, such as Drug abuse/ dependence, alcohol abuse/ dependence, heart, liver, kidney, lung, eye, blood, digestive diseases, etc.
2) A person who has a history of allergies to drugs or has a specific constitution (Alcohol hypersensitivity, etc.)
3) Those who may use the drug (antihistamines, adrenal cortical hormone agents) within one week before administered the study drug
4) Pregnant or nursing women
5) Those who are within 3 months of participating in other clinical trials
6) In addition, those who are deemed unsuitable for this study by the physician responsible for the research or the doctor sharing the research

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Uchida
Middle name
Last name Naoki

Organization

Showa University School of Medicine

Division name

Department of Clinical Pharmacology

Zip code

157-8577

Address

6-11-11 Kitakarasuyama Setagaya-ku, Tokyo

TEL

0333005254

Email

nuchida@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Uchida
Middle name
Last name Naoki

Organization

Showa University School of Medicine

Division name

Department of Clinical Pharmacology

Zip code

157-8577

Address

6-11-11 Kitakarasuyama Setagaya-ku, Tokyo

TEL

0333005254

Homepage URL


Email

nuchida@med.showa-u.ac.jp


Sponsor or person

Institute

Showa University School of Medicine
Department of Clinical Pharmacology

Institute

Department

Personal name



Funding Source

Organization

Japan Cosmetics Association

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Showa Univ. Karasuyama Hospital

Address

6-11-11 Kitakarasuyama

Tel

0333005247

Email

kawashima@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results

In the range of CBD concentrations of 0% to 1.5%, CBD was not observed of any skin irritating adverse effects.

Results date posted

2021 Year 03 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 02 Month 12 Day

Date of IRB

2021 Year 02 Month 15 Day

Anticipated trial start date

2021 Year 02 Month 15 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 12 Day

Last modified on

2021 Year 03 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049067


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name